Episode 66: A clot, a clot, I want it not – secondary prevention with antiplatelets

Submitted by admin on Wed, 2009-09-16 20:00

In episode 66, we embark on a journey of epic proportions; at least relative to our understanding.  With the help of Peter Loewen, we outline the anti-platelet options in secondary prevention of heart disease.  We discuss at length the use ASA and clopidogrel but also touch on additional agents like warfarin, dipyridamole and others.  Where the evidence is clear, we create opacit

The full content of this Podcast, including the audio file, is available to Premium Members only. Click to find out the benefits of having a Premium Membership.

Why Get A Premium Membership ?

Comments

A new trial was published in

Submitted by daniel_p (not verified) on Wed, 2010-04-14 23:35.

A new trial was published in the New England Journal of Medicine comparing aspirin with dual anti-platelet therapy (aspirin + clopidogrel) beyond 12 months in patients who had received drug-eluting stents. No differences were found between these groups.
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents

Post new comment

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.